ARNT and hepatocellular carcinoma: Several studies have shown that dysregulation of AHR in hepatocytes leads to steatosis and aberrant cholesterol metabolism [9–11], and increased expression of AHR and its binding partner, ARNT, has been noted in hepatocellular carcinoma (HCC) [12].